Source Credit:

RALEIGH –  Taysha Gene Therapies will add more than 200 jobs paying an average of some $120,000 as part of an expansion in Durham County.

The company chose the Triangle over Dallas, Texas, for a 160,000 square foot facility which will serve as its manufacturing site. It is based in Dallas.

It will invest $75 million as part of the expansion.

Taysha joins a growing number of companies in the Triangle area focused on gene therapies.

North Carolina’s Economic Investment Committee approved a state benefits package of more than $5 million for the project at a meeting Thursday morning.

“North Carolina has a thriving life sciences ecosystem with significant expertise in gene therapy manufacturing, and we are delighted to establish our manufacturing center in Durham,” said RA Session II, founder and CEO of Taysha, in a statement. “With our management team with technical and manufacturing know-how leading the charge, this leading facility will serve as a center of excellence for gene therapy development, from preclinical studies through commercialization, and will further Taysha’s leadership position in gene therapy as well as support our next phase of growth.”

Landing of $75M expansion of Texas-based Taysha adds to Triangle’s growing gene therapy hub